E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents

Angelo J Russo; Pellegrino G Magro; ZHEN HU; Wei-Wei LI; Rowayda Peters; Jennifer Mandola; Debabrata Banerjee; Joseph R Bertino

doi:10.1158/0008-5472.CAN-05-3725

Back

E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents

Journal article

Open access

Peer reviewed

E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents

Angelo J Russo, Pellegrino G Magro, ZHEN HU, Wei-Wei LI, Rowayda Peters, Jennifer Mandola, Debabrata Banerjee and Joseph R Bertino

Cancer research (Chicago, Ill.), Vol.66(14), pp.7253-7260

2006

DOI: https://doi.org/10.1158/0008-5472.CAN-05-3725

PMID: 16849574

Abstract

Biological and medical sciences

Medical sciences

Pharmacology. Drug treatments

Antineoplastic Agents

Tumors

Files and links (1)

url

https://doi.org/10.1158/0008-5472.CAN-05-3725View

Version of Record (VoR) Open

Metrics

10 Record Views

25 Times Cited - Web of Science

Details

Title: E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents
Creators: Angelo J Russo - The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, United States
Pellegrino G Magro - The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, United States
ZHEN HU - The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, United States
Wei-Wei LI - Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Rowayda Peters - The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, United States
Jennifer Mandola - The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, United States
Debabrata Banerjee - The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, United States
Joseph R Bertino - The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, United States
Publication Details: Cancer research (Chicago, Ill.), Vol.66(14), pp.7253-7260
Date published: 2006
Publisher: American Association for Cancer Research
Academic Unit: Bertino Office; Pharmacology (RWJMS)
Language: English
Resource Type: Journal article
Identifiers: 991031666171404646